Akkoc Ali, Aydin Cemil, Topaktas Ramazan, Kartalmis Mahir, Altin Selcuk, Isen Kenan, Metin Ahmet
Department of Urology, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.
Department of Urology, Selahaddin Eyyubi State Hospital, Diyarbakir, Turkey.
Int Braz J Urol. 2016 May-Jun;42(3):578-84. doi: 10.1590/S1677-5538.IBJU.2015.0256.
Postoperative urinary retention (POUR) is one of the most common complications after surgical procedures under spinal anaesthesia. Recent studies have shown the beneficial effects of alpha-adrenergic blockers in preventing POUR. The aim of this prospective study was to investigate and compare the prophylactic effects of tamsulosin and alfuzosin on POUR after urologic surgical procedures under spinal anaesthesia.
A total of 180 males who underwent elective urologic surgery were included in this study. The patients were randomly allocated into three Groups. The Group I received placebo. Patients in Group II were given 0.4mg of tamsulosin orally 14 and 2 hours before surgery. Patients in Group III were given 10mg of alfuzosin ER orally 10 and 2 hours before surgery. All patients were closely followed for 24 hours postoperatively and their episodes of urinary retentions were recorded.
There were 60 patients in each Group. Their mean age was 35.95±15.16 years. Fifteen patients in Group I (25%), 3 patients in Group II (5%) and 4 patients in Group III (6.7%) required catheterization because of urinary retention. In tamsulosin group and alfuzosin group, there were a significantly lower proportion of patients with POUR compared with the placebo Group (p=0.002 and p=0.006). The beneficial effects of tamsulosin and alfuzosin on POUR were similar between both Groups (p=0.697).
This study suggests that the use of prophylactic tamsulosin or alfuzosin can reduce the incidence of urinary retention and the need for catheterization after urologic surgical procedures under spinal anaesthesia.
术后尿潴留(POUR)是脊髓麻醉下手术最常见的并发症之一。最近的研究表明α-肾上腺素能阻滞剂在预防POUR方面具有有益作用。本前瞻性研究的目的是调查和比较坦索罗辛和阿夫唑嗪对脊髓麻醉下泌尿外科手术术后POUR的预防效果。
本研究共纳入180例接受择期泌尿外科手术的男性患者。患者被随机分为三组。第一组接受安慰剂。第二组患者在手术前14小时和2小时口服0.4mg坦索罗辛。第三组患者在手术前10小时和2小时口服10mg阿夫唑嗪缓释片。所有患者术后密切随访24小时,并记录其尿潴留发作情况。
每组有60例患者。他们的平均年龄为35.95±15.16岁。第一组有15例患者(25%)、第二组有3例患者(5%)、第三组有4例患者(6.7%)因尿潴留需要导尿。与安慰剂组相比,坦索罗辛组和阿夫唑嗪组POUR患者的比例显著降低(p = 0.002和p = 0.006)。两组之间坦索罗辛和阿夫唑嗪对POUR的有益作用相似(p = 0.697)。
本研究表明,预防性使用坦索罗辛或阿夫唑嗪可降低脊髓麻醉下泌尿外科手术后尿潴留的发生率及导尿需求。